首页 正文

Looking beyond the ER, PR, and HER2: what's new in the ARsenal for combating breast cancer?

{{output}}
Breast cancer (BrCa) is a complex and heterogeneous disease with diverse molecular subtypes, leading to varied clinical outcomes and posing significant treatment challenges. The increasing global burden of BrCa, particularly in low- and middle-income countries... ...